{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:04:10Z","timestamp":1779858250451,"version":"3.53.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M761501"],"award-info":[{"award-number":["2024M761501"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Support program of China Postdoctoral Science Foundation","award":["2025T181073"],"award-info":[{"award-number":["2025T181073"]}]},{"name":"Jiangsu Provincial Medical Key Laboratory","award":["ZDXYS202208"],"award-info":[{"award-number":["ZDXYS202208"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82205212"],"award-info":[{"award-number":["82205212"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08110-4","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:26:08Z","timestamp":1776180368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dissecting molecular heterogeneity in primary gastric cancer by IGFBP7-related analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuan-jie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-wen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-pin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-ping","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"3","key":"8110_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8110_CR2","first-page":"100845","volume":"41","author":"TI Mamun","year":"2024","unstructured":"Mamun TI, Younus S, Rahman MH. Gastric cancer\u2014Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: An updated review. Cancer Treat Res Commun. 2024;41:100845.","journal-title":"Cancer Treat Res Commun"},{"issue":"6","key":"8110_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.21147\/j.issn.1000-9604.2024.06.02","volume":"36","author":"J Wei","year":"2024","unstructured":"Wei J, Bu Z. Advances in gastric cancer treatment in 2024: Key breakthroughs and emerging trends. Chin J Cancer Res. 2024;36(6):592\u20135.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"8110_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13045-025-01698-y","volume":"18","author":"Y Chen","year":"2025","unstructured":"Chen Y, et al. The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis. J Hematol Oncol. 2025;18(1):42.","journal-title":"J Hematol Oncol"},{"key":"8110_CR5","doi-asserted-by":"publisher","first-page":"1355269","DOI":"10.3389\/fphar.2024.1355269","volume":"15","author":"X Lin","year":"2024","unstructured":"Lin X, et al. Dissecting gastric cancer heterogeneity and exploring therapeutic strategies using bulk and single-cell transcriptomic analysis and experimental validation of tumor microenvironment and metabolic interplay. Front Pharmacol. 2024;15:1355269.","journal-title":"Front Pharmacol"},{"key":"8110_CR6","doi-asserted-by":"publisher","first-page":"153303382093547","DOI":"10.1177\/1533033820935477","volume":"19","author":"RE Sexton","year":"2020","unstructured":"Sexton RE, et al. Gastric Cancer Heterogeneity and Clinical Outcomes. Technol Cancer Res Treat. 2020;19:1533033820935477.","journal-title":"Technol Cancer Res Treat"},{"issue":"11","key":"8110_CR7","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1002\/1878-0261.12948","volume":"15","author":"J Garcia-Pelaez","year":"2021","unstructured":"Garcia-Pelaez J, et al. Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges. Mol Oncol. 2021;15(11):2841\u201367.","journal-title":"Mol Oncol"},{"issue":"16","key":"8110_CR8","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1158\/0008-5472.CAN-24-4065","volume":"85","author":"X Xu","year":"2025","unstructured":"Xu X, et al. Genomic Analyses Reveal the Evolving Characteristics of Intestinal Metaplasia and Gastric Cancer. Cancer Res. 2025;85(16):3123\u201338.","journal-title":"Cancer Res"},{"key":"8110_CR9","doi-asserted-by":"publisher","first-page":"175883592210830","DOI":"10.1177\/17588359221083049","volume":"14","author":"A Ooki","year":"2022","unstructured":"Ooki A, Yamaguchi K. The dawn of precision medicine in diffuse-type gastric cancer. Ther Adv Med Oncol. 2022;14:17588359221083049.","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"8110_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41698-025-01052-y","volume":"9","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Li J. Immunotherapy for diffuse gastric cancer: challenges and new avenues. NPJ Precis Oncol. 2025;9(1):247.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"8110_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12307-009-0032-9","volume":"3","author":"Y Kitadai","year":"2010","unstructured":"Kitadai Y. Cancer-stromal cell interaction and tumor angiogenesis in gastric cancer. Cancer Microenviron. 2010;3(1):109\u201316.","journal-title":"Cancer Microenviron"},{"issue":"1","key":"8110_CR12","doi-asserted-by":"publisher","first-page":"22596","DOI":"10.1038\/s41598-024-73062-y","volume":"14","author":"YJ Liu","year":"2024","unstructured":"Liu YJ, et al. Integrated analysis to identify biological features and molecular markers of poorly cohesive gastric carcinoma (PCC). Sci Rep. 2024;14(1):22596.","journal-title":"Sci Rep"},{"key":"8110_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3389\/fonc.2020.00727","volume":"10","author":"L Jin","year":"2020","unstructured":"Jin L, et al. Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk. Front Oncol. 2020;10:727.","journal-title":"Front Oncol"},{"issue":"10","key":"8110_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jclinpath-2015-202987","volume":"68","author":"Y Sato","year":"2015","unstructured":"Sato Y, et al. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. J Clin Pathol. 2015;68(10):795\u2013801.","journal-title":"J Clin Pathol"},{"issue":"10","key":"8110_CR15","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.21037\/tcr-23-1055","volume":"12","author":"HW Xu","year":"2023","unstructured":"Xu HW, Wang MQ, Zhu SL. Analysis of IGFBP7 expression characteristics in pan-cancer and its clinical relevance to stomach adenocarcinoma. Transl Cancer Res. 2023;12(10):2596\u2013612.","journal-title":"Transl Cancer Res"},{"issue":"19","key":"8110_CR16","doi-asserted-by":"publisher","first-page":"e70080","DOI":"10.1111\/jcmm.70080","volume":"28","author":"W Mo","year":"2024","unstructured":"Mo W, et al. IGFBP7 regulates cell proliferation and migration through JAK\/STAT pathway in gastric cancer and is regulated by DNA and RNA methylation. J Cell Mol Med. 2024;28(19):e70080.","journal-title":"J Cell Mol Med"},{"key":"8110_CR17","doi-asserted-by":"publisher","first-page":"1421438","DOI":"10.3389\/fcell.2024.1421438","volume":"12","author":"KK Lit","year":"2024","unstructured":"Lit KK, Zhirenova Z, Blocki A. Insulin-like growth factor-binding protein 7 (IGFBP7): A microenvironment-dependent regulator of angiogenesis and vascular remodeling. Front Cell Dev Biol. 2024;12:1421438.","journal-title":"Front Cell Dev Biol"},{"key":"8110_CR18","doi-asserted-by":"crossref","unstructured":"Wu SG, et al. IGFBP7 drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer. Cancers (Basel). 2019;11(1).","DOI":"10.3390\/cancers11010036"},{"key":"8110_CR19","doi-asserted-by":"crossref","unstructured":"Cheng C, et al. A review of single-cell RNA-Seq annotation, integration, and cell-cell communication. Cells. 2023;12(15).","DOI":"10.3390\/cells12151970"},{"key":"8110_CR20","doi-asserted-by":"publisher","first-page":"13922","DOI":"10.3389\/abp.2025.13922","volume":"72","author":"G Molla Desta","year":"2025","unstructured":"Molla Desta G, Birhanu AG. Advancements in single-cell RNA sequencing and spatial transcriptomics: transforming biomedical research. Acta Biochim Pol. 2025;72:13922.","journal-title":"Acta Biochim Pol"},{"issue":"20","key":"8110_CR21","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/s41388-024-03012-5","volume":"43","author":"Y Dong","year":"2024","unstructured":"Dong Y, et al. ScRNA-seq of gastric cancer tissues reveals differences in the immune microenvironment of primary tumors and metastases. Oncogene. 2024;43(20):1549\u201364.","journal-title":"Oncogene"},{"issue":"7871","key":"8110_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","volume":"596","author":"A Rao","year":"2021","unstructured":"Rao A, et al. Exploring tissue architecture using spatial transcriptomics. Nature. 2021;596(7871):211\u201320.","journal-title":"Nature"},{"issue":"D1","key":"8110_CR23","doi-asserted-by":"publisher","first-page":"D1243","DOI":"10.1093\/nar\/gkae974","volume":"53","author":"G Perez","year":"2025","unstructured":"Perez G, et al. The UCSC Genome Browser database: 2025 update. Nucleic Acids Res. 2025;53(D1):D1243\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"8110_CR24","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"8110_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40537-023-00844-y","volume":"10","author":"Z Liu","year":"2023","unstructured":"Liu Z, et al. BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors. J Big Data. 2023;10(1):165.","journal-title":"J Big Data"},{"key":"8110_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1756-0500-3-18","volume":"3","author":"P L\u00f3pez-Romero","year":"2010","unstructured":"L\u00f3pez-Romero P, et al. Processing of Agilent microRNA array data. BMC Res Notes. 2010;3:18.","journal-title":"BMC Res Notes"},{"issue":"4","key":"8110_CR27","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/annonc\/mdy013","volume":"29","author":"JP Machiels","year":"2018","unstructured":"Machiels JP, et al. Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN). Ann Oncol. 2018;29(4):985\u201391.","journal-title":"Ann Oncol"},{"issue":"1","key":"8110_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12967-017-1174-z","volume":"15","author":"F Baty","year":"2017","unstructured":"Baty F, et al. 24\u00a0h-gene variation effect of combined bevacizumab\/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling. J Transl Med. 2017;15(1):66.","journal-title":"J Transl Med"},{"issue":"3","key":"8110_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10549-011-1679-8","volume":"129","author":"S Massarweh","year":"2011","unstructured":"Massarweh S, et al. A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer. Breast Cancer Res Treat. 2011;129(3):819\u201327.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"8110_CR30","first-page":"1","volume":"35","author":"PM Valero-Mora","year":"2010","unstructured":"Valero-Mora PM. ggplot2: Elegant Graphics for Data Analysis. J Stat Softw Book Reviews. 2010;35(1):1\u20133.","journal-title":"J Stat Softw Book Reviews"},{"key":"8110_CR31","doi-asserted-by":"crossref","unstructured":"Zhang P, et al. Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer. Cell Rep. 2019;27(6):1934\u20131947.e5.","DOI":"10.1016\/j.celrep.2019.04.052"},{"issue":"3","key":"8110_CR32","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.CD-21-0683","volume":"12","author":"V Kumar","year":"2022","unstructured":"Kumar V, et al. Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer. Cancer Discov. 2022;12(3):670\u201391.","journal-title":"Cancer Discov"},{"key":"8110_CR33","doi-asserted-by":"crossref","unstructured":"Sullivan KM, et al. Tumor and peritoneum-associated macrophage gene signature as a novel molecular biomarker in gastric cancer. Int J Mol Sci. 2024;25(7).","DOI":"10.3390\/ijms25074117"},{"key":"8110_CR34","doi-asserted-by":"publisher","first-page":"106644","DOI":"10.1016\/j.phrs.2022.106644","volume":"188","author":"YJ Liu","year":"2023","unstructured":"Liu YJ, et al. USP51\/ZEB1\/ACTA2 axis promotes mesenchymal phenotype in gastric cancer and is associated with low cohesion characteristics. Pharmacol Res. 2023;188:106644.","journal-title":"Pharmacol Res"},{"issue":"1","key":"8110_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12967-023-04056-z","volume":"21","author":"Z Tan","year":"2023","unstructured":"Tan Z, et al. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. J Transl Med. 2023;21(1):223.","journal-title":"J Transl Med"},{"key":"8110_CR36","doi-asserted-by":"crossref","unstructured":"Fan C, et al. irGSEA: the integration of single-cell rank-based gene set enrichment analysis. Brief Bioinform. 2024;25(4).","DOI":"10.1093\/bib\/bbae243"},{"issue":"6","key":"8110_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"16","key":"8110_CR38","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1093\/bioinformatics\/btab003","volume":"37","author":"J Alquicira-Hernandez","year":"2021","unstructured":"Alquicira-Hernandez J, Powell JE. Nebulosa recovers single-cell gene expression signals by kernel density estimation. Bioinformatics. 2021;37(16):2485\u20137.","journal-title":"Bioinformatics"},{"issue":"10","key":"8110_CR39","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1164\/rccm.202401-0078OC","volume":"210","author":"AY Zhao","year":"2024","unstructured":"Zhao AY, et al. Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis. Am J Respir Crit Care Med. 2024;210(10):1252\u201366.","journal-title":"Am J Respir Crit Care Med"},{"key":"8110_CR40","doi-asserted-by":"publisher","first-page":"1366096","DOI":"10.3389\/fimmu.2024.1366096","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. Integrative single-cell analysis of LUAD: elucidating immune cell dynamics and prognostic modeling based on exhausted CD8\u2009+\u2009T cells. Front Immunol. 2024;15:1366096.","journal-title":"Front Immunol"},{"issue":"6476","key":"8110_CR41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati GS, et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science. 2020;367(6476):405\u201311.","journal-title":"Science"},{"issue":"9","key":"8110_CR42","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/s41556-024-01469-w","volume":"26","author":"D Dimitrov","year":"2024","unstructured":"Dimitrov D, et al. LIANA+ provides an all-in-one framework for cell\u2013cell communication inference. Nat Cell Biol. 2024;26(9):1613\u201322.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"8110_CR43","doi-asserted-by":"publisher","first-page":"e00260","DOI":"10.1097\/BS9.0000000000000260","volume":"7","author":"Z Chen","year":"2025","unstructured":"Chen Z, et al. Single-cell transcriptomic dissection of two waves of endothelial-hematopoietic transition in a murine yolk sac. Blood Sci. 2025;7(4):e00260.","journal-title":"Blood Sci"},{"issue":"5","key":"8110_CR44","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/gutjnl-2024-332901","volume":"74","author":"SH Lee","year":"2025","unstructured":"Lee SH, et al. Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2\u2009+\u2009fibroblasts and STAT3-activated macrophages. Gut. 2025;74(5):714\u201327.","journal-title":"Gut"},{"key":"8110_CR45","doi-asserted-by":"crossref","unstructured":"Larsson L, et al. Semla: a versatile toolkit for spatially resolved transcriptomics analysis and visualization. Bioinformatics. 2023;39(10).","DOI":"10.1093\/bioinformatics\/btad626"},{"issue":"1","key":"8110_CR46","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41467-023-36062-6","volume":"14","author":"B Ru","year":"2023","unstructured":"Ru B, et al. Estimation of cell lineages in tumors from spatial transcriptomics data. Nat Commun. 2023;14(1):568.","journal-title":"Nat Commun"},{"key":"8110_CR47","doi-asserted-by":"crossref","unstructured":"Wang J. TFTF: An R-based integrative tool for decoding human transcription factor-target interactions. Biomolecules. 2024;14(7).","DOI":"10.3390\/biom14070749"},{"issue":"2","key":"8110_CR48","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gpb.2019.09.006","volume":"18","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, et al. hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteom Bioinf. 2020;18(2):120\u20138.","journal-title":"Genomics Proteom Bioinf"},{"issue":"D1","key":"8110_CR49","doi-asserted-by":"publisher","first-page":"D93","DOI":"10.1093\/nar\/gkz881","volume":"48","author":"C Feng","year":"2020","unstructured":"Feng C, et al. KnockTF: a comprehensive human gene expression profile database with knockdown\/knockout of transcription factors. Nucleic Acids Res. 2020;48(D1):D93\u2013100.","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"8110_CR50","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","volume":"26","author":"A Lachmann","year":"2010","unstructured":"Lachmann A, et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics. 2010;26(19):2438\u201344.","journal-title":"Bioinformatics"},{"issue":"D1","key":"8110_CR51","doi-asserted-by":"publisher","first-page":"D104","DOI":"10.1093\/nar\/gkaa1057","volume":"49","author":"S Kolmykov","year":"2021","unstructured":"Kolmykov S, et al. GTRD: an integrated view of transcription regulation. Nucleic Acids Res. 2021;49(D1):D104\u201311.","journal-title":"Nucleic Acids Res"},{"key":"8110_CR52","doi-asserted-by":"crossref","unstructured":"Oki S, et al. ChIP-Atlas: a data-mining suite powered by full integration of public ChIP-seq data. EMBO Rep. 2018;19(12).","DOI":"10.15252\/embr.201846255"},{"issue":"1","key":"8110_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-017-0765-y","volume":"21","author":"H In","year":"2018","unstructured":"In H, et al. The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging. Gastric Cancer. 2018;21(1):1\u20139.","journal-title":"Gastric Cancer"},{"issue":"2","key":"8110_CR54","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"issue":"1","key":"8110_CR55","doi-asserted-by":"publisher","first-page":"e70301","DOI":"10.1111\/jcmm.70301","volume":"29","author":"M Wang","year":"2025","unstructured":"Wang M, et al. Artificial Intelligence-Guided Identification of IGFBP7 as a Critical Indicator in Lactic Metabolism Determines Immunotherapy Response in Stomach Adenocarcinoma. J Cell Mol Med. 2025;29(1):e70301.","journal-title":"J Cell Mol Med"},{"issue":"21","key":"8110_CR56","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.1158\/1078-0432.CCR-10-2774","volume":"17","author":"D Chen","year":"2011","unstructured":"Chen D, et al. Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma. Clin Cancer Res. 2011;17(21):6693\u2013701.","journal-title":"Clin Cancer Res"},{"key":"8110_CR57","doi-asserted-by":"publisher","first-page":"108703","DOI":"10.1016\/j.compbiomed.2024.108703","volume":"178","author":"X Li","year":"2024","unstructured":"Li X, et al. Diffuse tumors: Molecular determinants shared by different cancer types. Comput Biol Med. 2024;178:108703.","journal-title":"Comput Biol Med"},{"issue":"1","key":"8110_CR58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41597-025-04381-6","volume":"12","author":"MN Gondal","year":"2025","unstructured":"Gondal MN, Cieslik M, Chinnaiyan AM. Integrated cancer cell-specific single-cell RNA-seq datasets of immune checkpoint blockade-treated patients. Sci Data. 2025;12(1):139.","journal-title":"Sci Data"},{"key":"8110_CR59","doi-asserted-by":"publisher","first-page":"175883592210830","DOI":"10.1177\/17588359221083049","volume":"14","author":"A Ooki","year":"2022","unstructured":"Ooki A, Yamaguchi K. The dawn of precision medicine in diffuse-type gastric cancer. Therapeutic Adv Med Oncol. 2022;14:17588359221083049.","journal-title":"Therapeutic Adv Med Oncol"},{"issue":"1","key":"8110_CR60","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13046-025-03527-z","volume":"44","author":"L Liu","year":"2025","unstructured":"Liu L, et al. Crosstalk between heterogeneous cancer-associated fibroblast subpopulations and the immune system in breast cancer: key players and promising therapeutic targets. J Experimental Clin Cancer Res. 2025;44(1):263.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"1","key":"8110_CR61","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","volume":"10","author":"C Lee","year":"2025","unstructured":"Lee C, et al. Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Signal Transduct Target Therapy. 2025;10(1):170.","journal-title":"Signal Transduct Target Therapy"},{"key":"8110_CR62","doi-asserted-by":"publisher","first-page":"118023","DOI":"10.1016\/j.biopha.2025.118023","volume":"186","author":"H Mahaki","year":"2025","unstructured":"Mahaki H, et al. Targeting VEGF signaling for tumor microenvironment remodeling and metastasis inhibition: Therapeutic strategies and insights. Biomed Pharmacother. 2025;186:118023.","journal-title":"Biomed Pharmacother"},{"key":"8110_CR63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/HP.S93413","volume":"3","author":"B Muz","year":"2015","unstructured":"Muz B, et al. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl). 2015;3:83\u201392.","journal-title":"Hypoxia (Auckl)"},{"issue":"1","key":"8110_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","volume":"10","author":"Y Li","year":"2025","unstructured":"Li Y, et al. Invasion and metastasis in cancer: molecular insights and therapeutic targets. Signal Transduct Target Therapy. 2025;10(1):57.","journal-title":"Signal Transduct Target Therapy"},{"key":"8110_CR65","doi-asserted-by":"crossref","unstructured":"Sun Y, et al. Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy. Sci Transl Med. 2021;13(604).","DOI":"10.1126\/scitranslmed.abc8922"},{"issue":"1","key":"8110_CR66","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12935-023-03044-z","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization. Cancer Cell Int. 2023;23(1):189.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"8110_CR67","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.hlc.2023.02.005","volume":"32","author":"M Billah","year":"2023","unstructured":"Billah M, et al. Early Growth Response-1: Friend or Foe in the Heart? Heart. Lung Circulation. 2023;32(5):e23\u201335.","journal-title":"Lung Circulation"},{"issue":"22","key":"8110_CR68","doi-asserted-by":"publisher","first-page":"e023539","DOI":"10.1161\/JAHA.121.023539","volume":"10","author":"LM Khachigian","year":"2021","unstructured":"Khachigian LM. Early Growth Response-1, an Integrative Sensor in Cardiovascular and Inflammatory Disease. J Am Heart Assoc. 2021;10(22):e023539.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"8110_CR69","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2337\/db13-0032","volume":"63","author":"S Vedantham","year":"2014","unstructured":"Vedantham S, et al. Aldose Reductase Drives Hyperacetylation of Egr-1 in Hyperglycemia and Consequent Upregulation of Proinflammatory and Prothrombotic Signals. Diabetes. 2014;63(2):761\u201374.","journal-title":"Diabetes"},{"key":"8110_CR70","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fcell.2020.00747","volume":"8","author":"N Clere","year":"2020","unstructured":"Clere N, Renault S, Corre I. Endothelial-to-Mesenchymal Transition in Cancer. Front Cell Dev Biol. 2020;8:747.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"8110_CR71","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12964-025-02028-y","volume":"23","author":"C Qian","year":"2025","unstructured":"Qian C, et al. Broadening horizons: molecular mechanisms and disease implications of endothelial-to-mesenchymal transition. Cell Communication Signal. 2025;23(1):16.","journal-title":"Cell Communication Signal"},{"issue":"10","key":"8110_CR72","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/nbt.2967","volume":"32","author":"AA Pollen","year":"2014","unstructured":"Pollen AA, et al. Low-coverage single-cell mRNA sequencing reveals cellular heterogeneity and activated signaling pathways in developing cerebral cortex. Nat Biotechnol. 2014;32(10):1053\u20138.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"8110_CR73","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1080\/15548627.2023.2281156","volume":"20","author":"MJ Livingston","year":"2024","unstructured":"Livingston MJ, et al. Autophagy activates EGR1 via MAPK\/ERK to induce FGF2 in renal tubular cells for fibroblast activation and fibrosis during maladaptive kidney repair. Autophagy. 2024;20(5):1032\u201353.","journal-title":"Autophagy"},{"issue":"4","key":"8110_CR74","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s13402-024-00931-z","volume":"47","author":"D Coursier","year":"2024","unstructured":"Coursier D, Calvo F. CAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance. Cell Oncol. 2024;47(4):1091\u2013112.","journal-title":"Cell Oncol"},{"key":"8110_CR75","doi-asserted-by":"publisher","first-page":"1582532","DOI":"10.3389\/fimmu.2025.1582532","volume":"16","author":"X Lan","year":"2025","unstructured":"Lan X, et al. Revisiting the role of cancer-associated fibroblasts in tumor microenvironment. Front Immunol. 2025;16:1582532.","journal-title":"Front Immunol"},{"key":"8110_CR76","doi-asserted-by":"crossref","unstructured":"Kang D, Kim IH. Molecular mechanisms and potential rationale of immunotherapy in peritoneal metastasis of advanced gastric cancer. Biomedicines. 2022;10(6).","DOI":"10.3390\/biomedicines10061376"},{"issue":"3","key":"8110_CR77","doi-asserted-by":"publisher","first-page":"e15914","DOI":"10.15252\/emmm.202215914","volume":"15","author":"S Bootsma","year":"2023","unstructured":"Bootsma S, Bijlsma MF, Vermeulen L. The molecular biology of peritoneal metastatic disease. EMBO Mol Med. 2023;15(3):e15914.","journal-title":"EMBO Mol Med"},{"issue":"21","key":"8110_CR78","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3748\/wjg.v12.i21.3297","volume":"12","author":"JC Becker","year":"2006","unstructured":"Becker JC, et al. Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy. World J Gastroenterol. 2006;12(21):3297\u2013305.","journal-title":"World J Gastroenterol"},{"key":"8110_CR79","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0378-1119(03)00730-3","volume":"315","author":"M Fu","year":"2003","unstructured":"Fu M, et al. Egr-1 target genes in human endothelial cells identified by microarray analysis. Gene. 2003;315:33\u201341.","journal-title":"Gene"},{"key":"8110_CR80","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3389\/fonc.2020.01066","volume":"10","author":"D Zhang","year":"2020","unstructured":"Zhang D, et al. VCAM1 Promotes Tumor Cell Invasion and Metastasis by Inducing EMT and Transendothelial Migration in Colorectal Cancer. Front Oncol. 2020;10:1066.","journal-title":"Front Oncol"},{"issue":"35","key":"8110_CR81","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1038\/s41388-019-0873-8","volume":"38","author":"L Li","year":"2019","unstructured":"Li L, et al. EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis. Oncogene. 2019;38(35):6241\u201355.","journal-title":"Oncogene"},{"key":"8110_CR82","doi-asserted-by":"crossref","unstructured":"Kazakova A, et al. Interaction of tumor\u2013associated macrophages with stromal and immune components in solid tumors: research progress (Review). Int J Oncol. 2023;62(2).","DOI":"10.3892\/ijo.2023.5480"},{"key":"8110_CR83","doi-asserted-by":"crossref","unstructured":"Kadomoto S, Izumi K, Mizokami A. Roles of CCL2-CCR2 axis in the tumor microenvironment. Int J Mol Sci. 2021;22(16).","DOI":"10.3390\/ijms22168530"},{"issue":"20","key":"8110_CR84","first-page":"11067","volume":"15","author":"K Shi","year":"2023","unstructured":"Shi K, et al. HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma. Aging. 2023;15(20):11067\u201391.","journal-title":"Aging"},{"issue":"9","key":"8110_CR85","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41388-021-02174-w","volume":"41","author":"A DiNatale","year":"2022","unstructured":"DiNatale A, et al. Subsets of cancer cells expressing CX3CR1 are endowed with metastasis-initiating properties and resistance to chemotherapy. Oncogene. 2022;41(9):1337\u201351.","journal-title":"Oncogene"},{"issue":"1","key":"8110_CR86","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13046-024-03195-5","volume":"43","author":"Z Yao","year":"2024","unstructured":"Yao Z, et al. Focusing on CD8(+) T-cell phenotypes: improving solid tumor therapy. J Exp Clin Cancer Res. 2024;43(1):266.","journal-title":"J Exp Clin Cancer Res"},{"key":"8110_CR87","doi-asserted-by":"publisher","first-page":"107126","DOI":"10.1016\/j.intimp.2020.107126","volume":"89","author":"S Fan","year":"2020","unstructured":"Fan S, et al. Association between tumor mutation burden and immune infiltration in ovarian cancer. Int Immunopharmacol. 2020;89:107126.","journal-title":"Int Immunopharmacol"},{"key":"8110_CR88","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.lungcan.2022.01.007","volume":"166","author":"Y Li","year":"2022","unstructured":"Li Y, et al. The genomic mutational landscape and its correlation with TMB, PD-L1 expression and CD8(+) T cell infiltration in Chinese lung large cell neuroendocrine carcinoma. Lung Cancer. 2022;166:161\u20139.","journal-title":"Lung Cancer"},{"issue":"10","key":"8110_CR89","doi-asserted-by":"publisher","first-page":"e30986","DOI":"10.1016\/j.heliyon.2024.e30986","volume":"10","author":"J Wang","year":"2024","unstructured":"Wang J, et al. IGFBP7 promotes gastric cancer by facilitating epithelial-mesenchymal transition of gastric cells. Heliyon. 2024;10(10):e30986.","journal-title":"Heliyon"},{"issue":"6","key":"8110_CR90","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI36183","volume":"119","author":"M Zeisberg","year":"2009","unstructured":"Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119(6):1429\u201337.","journal-title":"J Clin Invest"},{"issue":"1","key":"8110_CR91","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12967-025-06422-5","volume":"23","author":"Y Xie","year":"2025","unstructured":"Xie Y, et al. Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges. J Transl Med. 2025;23(1):386.","journal-title":"J Transl Med"},{"issue":"8","key":"8110_CR92","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1007\/s10620-021-07250-5","volume":"67","author":"J Yan","year":"2022","unstructured":"Yan J, et al. EGR1-CCL2 Feedback Loop Maintains Epithelial-Mesenchymal Transition of Cisplatin-Resistant Gastric Cancer Cells and Promotes Tumor Angiogenesis. Dig Dis Sci. 2022;67(8):3702\u201313.","journal-title":"Dig Dis Sci"},{"key":"8110_CR93","doi-asserted-by":"publisher","first-page":"155380","DOI":"10.1016\/j.metabol.2022.155380","volume":"140","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Hepatocyte Ninjurin2 promotes hepatic stellate cell activation and liver fibrosis through the IGF1R\/EGR1\/PDGF-BB signaling pathway. Metabolism. 2023;140:155380.","journal-title":"Metabolism"},{"issue":"2","key":"8110_CR94","doi-asserted-by":"publisher","first-page":"e55522","DOI":"10.1371\/journal.pone.0055522","volume":"8","author":"HS Lee","year":"2013","unstructured":"Lee HS, et al. Low SP1 expression differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma. PLoS ONE. 2013;8(2):e55522.","journal-title":"PLoS ONE"},{"issue":"15","key":"8110_CR95","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1111\/jcmm.16760","volume":"25","author":"T Ye","year":"2021","unstructured":"Ye T, et al. The subtype-specific molecular function of SPDEF in breast cancer and insights into prognostic significance. J Cell Mol Med. 2021;25(15):7307\u201320.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"8110_CR96","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11033-025-11178-8","volume":"53","author":"B Polat","year":"2025","unstructured":"Polat B, et al. NOS1AP: a potential subtype-specific dual role as a tumor suppressor and oncogene in breast cancer subtypes. Mol Biol Rep. 2025;53(1):7.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"8110_CR97","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13046-025-03485-6","volume":"44","author":"L Bao","year":"2025","unstructured":"Bao L, et al. Pyrotinib targeted EGFR\/GRP78 mediated cell apoptosis in high EGFR gene copy number gastric cancer. J Exp Clin Cancer Res. 2025;44(1):245.","journal-title":"J Exp Clin Cancer Res"},{"key":"8110_CR98","doi-asserted-by":"publisher","first-page":"898493","DOI":"10.3389\/fimmu.2022.898493","volume":"13","author":"X Yi","year":"2022","unstructured":"Yi X, et al. IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer. Front Immunol. 2022;13:898493.","journal-title":"Front Immunol"},{"issue":"10","key":"8110_CR99","first-page":"2368","volume":"11","author":"CD93 Blockade Stabilizes Tumor Vasculature to Improve Therapy Response","year":"2021","unstructured":"CD93 Blockade Stabilizes Tumor Vasculature to Improve Therapy Response. Cancer Discov. 2021;11(10):2368\u20132368.","journal-title":"Cancer Discov"},{"key":"8110_CR100","unstructured":"Phase A1 multicenter, open-label, dose escalation and expansion study to assess safety, tolerability, pharmacokinetics, pharmacodynamics of DCSZ11 as a monotherapy and in combination in patients with advanced or metastatic solid tumors. 2023."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08110-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08110-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08110-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:35:08Z","timestamp":1779856508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08110-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8110"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08110-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study\u2019s protocol was approved by the ethics committee of Affiliated Hospital of Nanjing University of Chinese Medicine, and informed consent was obtained from clinicians and patients (Ethics approval number: 2022NL-162-02, Ethics approval date: 2022-09-16). The study was in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent to publish personal data was obtained from the patients and\/or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest. All authors contributed to data analysis, drafting, or revising of the article; agree on the journal to which the article is being submitted; provided final approval of the version to be published; and agree to be accountable for all aspects of the work. Prior to the commencement of data collection, the first author obtained written consent from all participants concerning participation and subsequent publication of the study results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"705"}}